Navigation Links
Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
Date:10/27/2007

Dispelling a common myth, researchers from the Johns Hopkins Childrens Center say vaginal reconstruction should be a matter of preference for most teens or adult women born with a type of inter-sex condition marked by the presence of both female and male genitals. The findings of the research are being presented at the American Academy of Pediatrics Conference Oct. 26 through Oct. 30 in San Francisco.

Women with complete androgen insensitivity are born with relatively shallow vaginas that may or may not require surgical repair and with undescended testes that do require removal.

Vaginal surgery, if needed or wanted, should be done after puberty, when physical development is complete and a girl or a woman is mature enough to make a decision, researchers say.

It is a common misconception in the general public and quite often among doctors that most girls born with this condition should have vaginal reconstruction in order to be sexually active, says lead investigator Todd Purves, M.D. Ph.D., a urologist at Hopkins Childrens. Our findings show that, on the contrary, most young women choose not to have the surgery, have vaginal depths that are within normal parameters and can lead active sexual lives.

In their study of 29 women born with the syndrome, researchers found that 38 percent chose to have vaginal surgery. Comparing those who had surgery with those who did not, researchers found that both groups had similar rates of sexual activity: Eighty percent of those who chose not to have surgery were sexually active, compared to 70 percent of those who had surgery.

As surgeons, we need to make sure that the parents of babies with this disorder understand that their daughter may not even need vaginal surgery, and if she does, it is a decision that should wait until after adolescence, Purves says.

Gender identity in women born with this condition is almost always female.


'/>"/>

Contact: Katerina Pesheva
epeshev1@jhmi.edu
410-926-6780
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1

Related biology news :

1. Vaginal gel may provide a new approach to HIV prevention
2. UCSF study will test new vaginal microbicide for herpes and HIV
3. Fat stem cells being studied as option for breast reconstruction
4. Tissue engineering for craniofacial reconstruction
5. A much-needed shot in the arm for HIV vaccine development
6. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
7. Clear rules needed to govern deep sea bioprospecting: UNU
8. Quick identification needed to save Floridas citrus industry from devastating disease
9. Womb needed for proper brain development
10. Molecular research suggest shift needed in how some drugs are created
11. Gene needed for butterfly transformation also key for insects like grasshoppers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...26, 2009) Whitehead researchers have developed a ...oint specific genes and proteins used by pathogens...st human cell cultures genes are present in two co...he mother. Gene inactivation by mutation is theref...ed, the second copy usually remains active and tak...
(Date:11/25/2009)... have easy lives. In addition to mammalian immune ...nemies called bacteriophages, viruses that kill ha...l, bacteria and another class of microorganisms ca...ents such as deep-sea volcanic vents) manage just ...-in defense system that helps protect them from ma...
(Date:11/25/2009)...ssistant professors recently received funding from... research beneficial to understanding the environm...her Blackwood, assistant professor in the Departme...upport two separate research projects. , His fir...ommunities and Functions from the Leaf to the Land...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Bayer CropScience Announces Investment of 2425 Million for Institute Site 13702 1Bayer CropScience Announces Investment of 2425 Million for Institute Site 13702 2Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 1Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 2Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 3Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 4Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 1Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 2Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 3
... is available in Spanish . , Contributing to t...e use of an only or a few species); using examples...ies and promoting the participation of experts in ...ommendations town councils should consider when de...at is the opinion of Paloma Carianos Gonzlez , re...
... 2008 -- Underwater wi-fi, music over the internet...hales find their favorite salmon, detecting danger...ryngectomy, rhythm and movement disorders, visuali... a possible way to save manatees from collisions w...will be covered at the 156th meeting of the Acoust...
...t time, scientists have decoded the complete DNA o...myelogenous leukemia - to its genetic roots. A lar...nd the Siteman Cancer Center at Washington Univers...genome of the patient - a woman in her 50s who ult...r leukemia cells, to identify genetic changes uniq...
Other Biology News:Expert recommends town councils to design low-allergy impact green spaces 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 3Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 4Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 5Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 6Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 7Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 8Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 9Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 10Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 11Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 12Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 13Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 14Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 15Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 16Washington University scientists first to sequence genome of cancer patient 2Washington University scientists first to sequence genome of cancer patient 3Washington University scientists first to sequence genome of cancer patient 4Washington University scientists first to sequence genome of cancer patient 5
(Date:11/27/2009)... A mechanised blue dye test alternative ...quality assurance one step closer for pharma-compa...esting machine developed by Sepha for use with ... several local and global pharma-companies such as...y assurance and productivity improvements on the p...
(Date:11/25/2009)... BOSTON, Nov. 25 Biotech firm Repl...omic data from the 1918 pandemic through the predi...pandemic, today issued its latest biochemical anal...hality of the H1N1 ("Swine Flu") virus has dropped...s current outbreak in the spring of 2009 to restin...
(Date:11/25/2009)...AM, ON, Nov. 25 /PRNewswire/ - Cytochroma today an... Board of Directors. Dr. Moldt will replace Mr. Ul...mpany,s Board. The number of Board members remains...sed to welcome Peter Moldt to the board and look f...nce as Cytochroma continues to make progress in be...
(Date:11/25/2009)...DIEGO, Nov. 25 Ardea Bio...at Barry D. Quart, Pharm.D., president and chief e...y 21st Annual Health Care Conference. , ,Presenta...nnual Health Care Conference,Date: Tuesday, D...Location: The New York Palace Hotel, New York, NY...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) a... a corporate overview at the upcoming Deutsche Ban...009 at 8:40 a.m. ET at the Intercontinental Hotel,... company presentation can be accessed under "Calen...www.idenix.com . Please log in approximately 5-1...
...Y, MAY 18, 2009 , , SAN DIEGO, May 11 Neurocrin...day that Kevin Gorman, President and Chief Executi...nting at the Deutsche Bank 34th Annual Health Care... takes place Monday, May 18, 2009 at 5:05 p.m. Eas...resentation will be simultaneously webcast and may...
... Neurologists to Plan Next Clinical Studies , , O... (OTC Bulletin Board: TBIO) and Power3 Medical Pro...the clinical introduction of the NuroPro(R) AD and...,s disease at the 2009 American Academy of Neurolo...clinicians distinguish patients with Alzheimer,s a...
Other Biology Technology:Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 3Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 4Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 5
...es optimized reagents and protocols for the rapid ...rtion of group II introns. The method exploits the...zes a simple PCR step to re-target the TargeTron g...t genome. Utility of the technology has been demon...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: